Bio2Business is pleased to welcome CARBOGEN AMCIS as a Gold Sponsor at BOS Manchester 2020. CARBOGEN AMCIS experts will deliver a 15 minute presentation on the 18th November, 10.45-11.00 in the CMC Small Molecule Track and you can meet their delegates at booth number 33. Further details regarding the presentation theme will follow. CARBOGEN AMCIS, a member of the Dishman Group, provide drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development.
To find out more about the full breadth of CARBOGEN AMCIS services and capabilities, click here to visit the website. In addition, click here to view the recent (6th August 2019) press release reporting the successful FDA inspection of the Hunzenschwil (Neuland), Switzerland API manufacturing site. The Hunzenschwil facility is one of CARBOGEN AMCIS’ four sites to offer development and manufacturing facilities for highly potent compounds. It manufactures products according to cGMP standards and is routinely inspected by Swissmedic, the FDA and external customers.